Tech Company Financing Transactions
Renata Medical Funding Round
ARCHIMED and private investors participated in a $25 million Series D venture round for Renata Medical. The financing round was announced on 8/19/2026.
Transaction Overview
Company Name
Announced On
8/19/2026
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series D
Investors
ARCHIMED (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support expanded U.S. commercialization efforts for the Minima Stent System, enter international markets, advance its pipeline of pediatric-specific CHD technology, and support continued clinical evidence generation.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4675 MacArthur Court 1150
Newport Beach, CA 92660
USA
Newport Beach, CA 92660
USA
Phone
Undisclosed
Website
Email Address
Overview
Every 15 minutes, a child is born with a congenital heart defect (CHD). These children often need multiple surgeries to treat their condition -- sometimes before their first birthday. At Renata, we are focused on serving unmet congenital needs by delivering safe and adaptable therapies designed for a lifetime of growth. In partnership with world-renowned physicians who dedicate their lives to treating children with CHD, Renata is driven to develop transformational solutions for young CHD patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dustin Armer
Chief Medical Officer
Evan Zahn
Chief Operating Officer
Eason Abbott
Browse more venture capital transactions:
Prev: 8/19/2026: Prevalent AI venture capital transaction
Next: 8/19/2026: ALSO. venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs